DRUG

Bright Minds Biosciences
DRUG

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $330K invested in Bright Minds Biosciences in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$29.3K
2
+$17K
3
+$4.95K
4
UBS Group
UBS Group
Switzerland
+$889

Top Sellers

1
-$3.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$273K
2
$24K
3
$17K
4
$15K
5
$889
6
$143
7
$1